Citigroup
LKFT

Citigroup’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Citigroup’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6K Sell
354
-144
-29% -$4.09K ﹤0.01% 5238
2026
Q1 		$14.9K Buy
498
+94
+23% +$3.11K ﹤0.01% 4908
2025
Q4 		$13.2K Sell
404
-13,449
-97% -$434K ﹤0.01% 4979
2025
Q3 		$480K Buy
13,853
+13,077
+1,685% +$418K ﹤0.01% 3603
2025
Q2 		$21.7K Sell
776
-28,922
-97% -$775K ﹤0.01% 5055
2025
Q1 		$746K Sell
29,698
-157
-0.5% -$3.97K ﹤0.01% 3449
2024
Q4 		$821K Sell
29,855
-193
-0.6% -$5.38K ﹤0.01% 3511
2024
Q3 		$865K Sell
30,048
-158
-0.5% -$4.3K ﹤0.01% 3365
2024
Q2 		$749K Sell
30,206
-24,531
-45% -$696K ﹤0.01% 3110
2024
Q1 		$1.76M Sell
54,737
-73,112
-57% -$2.72M ﹤0.01% 2533
2023
Q4 		$5.2M Buy
127,849
+37,163
+41% +$1.37M ﹤0.01% 1564
2023
Q3 		$3.13M Buy
90,686
+89,451
+7,243% +$3.48M ﹤0.01% 1694
2023
Q2 		$50.2K Sell
1,235
-105
-8% -$4.28K ﹤0.01% 4645
2023
Q1 		$51.8K Sell
1,340
-393
-23% -$16.2K ﹤0.01% 4251
2022
Q4 		$76.9K Buy
1,733
+390
+29% +$16.4K ﹤0.01% 4124
2022
Q3 		$58K Sell
1,343
-126
-9% -$6.46K ﹤0.01% 4324
2022
Q2 		$82K Sell
1,469
-4,481
-75% -$266K ﹤0.01% 4316
2022
Q1 		$369K Sell
5,950
-1,378
-19% -$84.3K ﹤0.01% 3709
2021
Q4 		$404K Sell
7,328
-779
-10% -$40.6K ﹤0.01% 3936
2021
Q3 		$426K Sell
8,107
-986
-11% -$58.5K ﹤0.01% 3716
2021
Q2 		$626K Buy
9,093
+8,666
+2,030% +$661K ﹤0.01% 3544
2021
Q1 		$33K Sell
427
-99,964
-100% -$9.21M ﹤0.01% 4946
2020
Q4 		$9.94M Sell
100,391
-174
-0.2% -$21.3K 0.01% 1556
2020
Q3 		$14.3M Sell
100,565
-4,054
-4% -$676K 0.01% 1120
2020
Q2 		$20.6M Sell
104,619
-177
-0.2% -$36.7K 0.02% 810
2020
Q1 		$20.5M Buy
104,796
+99,740
+1,973% +$21.5M 0.02% 718
2019
Q4 		$1.05M Buy
5,056
+892
+21% +$165K ﹤0.01% 3706
2019
Q3 		$635K Buy
4,164
+3,521
+548% +$577K ﹤0.01% 4113
2019
Q2 		$83K Buy
643
+513
+395% +$60.9K ﹤0.01% 6036
2019
Q1 		$15K Buy
+130
New +$13.1K ﹤0.01% 7087
2018
Q2 		– Sell
-47
Closed -$5K – 7647
2018
Q1 		$5K Sell
47
-308
-87% -$33.2K ﹤0.01% 7202
2017
Q4 		$33K Buy
+355
New +$33.6K ﹤0.01% 6445
2016
Q1 		– Sell
-49
Closed -$3K – 7552
2015
Q4 		$3K Buy
49
+30
+158% +$1.53K ﹤0.01% 7183
2015
Q3 		$1K Buy
+19
New +$1.09K ﹤0.01% 7160

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Citigroup's LKFT Position: Q2 2026 in Review

Citigroup reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 29% in Q2 2026, selling an estimated $4.09K and leaving 354 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5238.

Citigroup first reported a position in LKFT in Q3 2015 and has held it in 34 quarters since. The position peaked at $20.6M in Q2 2020. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Citigroup held 354 shares of Lakefront Biotherapeutics American Depositary Shares worth $10.6K as of Q2 2026.
  • Citigroup sold 144 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $4.09K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5238 holding.
  • Citigroup first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 34 quarters since.
  • Citigroup's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.6M in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.